Role of stenotrophomonas maltophilia infection in CF pulmonary exacerbations

A. M. Vasile, I. V. Stan, M. Craiu, V. D. Comanici (Bucharest, Romania)

Source: Annual Congress 2013 –Difficult and rare respiratory infections
Session: Difficult and rare respiratory infections
Session type: Poster Discussion
Number: 2071
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. M. Vasile, I. V. Stan, M. Craiu, V. D. Comanici (Bucharest, Romania). Role of stenotrophomonas maltophilia infection in CF pulmonary exacerbations. Eur Respir J 2013; 42: Suppl. 57, 2071

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inhaled colistin in patients with non - cystic fibrosis bronchiectasis and chronic pseudomonas aeruginosa bronquial infection
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016


Patients with no cystic fibrosis bronchiectasis colonized by pseudomonas aeruginosa: Role of inhaled colistin
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014


Nicotinamide and bacterial killing in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Cystic fibrosis: Achromobacter xylosoxidans colonized patients have more severe respiratory disease
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013

Adaptation of prevotella during acute infectious pulmonary exacerbation
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

Genotypic studies of pseudomonas aeruginosa isolates from adult non-cystic fibrosis bronchiectasis patients
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015

Azithromycin therapy and pseudomonas aeruginosa isolation in a non-cystic fibrosis bronchiectasis cohort
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015


Frequency and pathogenicity of rhinovirus associated pulmonary exacerbations in patients with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013

Temperate bacteriophages of pseudomonas aeruginosa as markers of bacterial adaptation in CF and non-CF bronchiectasis
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014


A comprehensive analysis of the impact of pseudomonas aeruginosa colonisation in adult bronchiectasis
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015


Exacerbations in non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014


Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections
Source: Eur Respir J 2012; 40: 227-238
Year: 2012



Azithromycin in chronic respiratory infections with pseudomonas aeruginosa in patients without cystic fibrosis
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008


Efficacy of ciprofloxacin against resistant mucoid or non-mucoid P. aeruginosa isolated from non-cystic fibrosis bronchiectasis (NCFB) patients considering lung pharmacokinetics after ciprofloxacin DPI treatment
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Clinical phenotypes in non-cystic fibrosis bronchiectasis (NCFBE)
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014

Epidemiology and natural history of Pseudomonas aeruginosa airway infections in non-cystic fibrosis bronchiectasis
Source: ERJ Open Res, 4 (2) 00162-2017; 10.1183/23120541.00162-2017
Year: 2018



Pseudomonas aeruginosa from CF airways uses various strategies to outcompete staphylococcus aureus
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016


The spectrum of Nocardia lung disease in cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015


Effectiveness of inhaled colistin by iNeb® device in non-CF bronchiectasis and chronic pseudomonas infection
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Year: 2015


Eradication regime of methicillin resistant staphylococcus aureus lung infection in cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013